NeoStem, Inc. (AMEX: NBS), an international biopharmaceutical company focused on accelerating the development of proprietary cellular therapies, has adult stem cell operations in the U.S., a network of adult stem cell therapeutic providers in China, and a 51% ownership in a profitable Chinese generic pharmaceutical manufacturing company. The Company aims to become a single source for collection, storage, manufacturing, therapeutic development and transportation of cells for cell based medicine and regenerative science globally. For further information, visit the Company’s Web site at www.neostem.com.

Noble Financial, a research driven, full-service investment banking boutique, is as discriminating with its invitations to institutional investors as it is with the companies invited to present. Rather than just focusing on crowding the conference floor, Noble Financial carefully invites a smaller audience of investors with a large appetite for the companies presenting; quality always trumps quantity. For more information or to view webcasts of today’s presentations, visit www.noblefcm.com.

Let us hear your thoughts below: